Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

<b>Multitarget-Directed Multiple Ligands in Anti-VEGF Resistant Glioblastoma Therapeutics: An in Silico Approach to Identify Potential Phytochemicals</b>

View through CrossRef
Angiogenesis is an important process in tumor progression. Vascular endothelial growth factor (VEGF) is the key factor regulating angiogenesis, and hence, anti-VEGF therapy is considered a useful therapeutic approach in tumor conditions. However, the drug resistance and lack of efficacy of existing drugs limit the potential of such a therapeutic approach in certain cases, and the tumor growth will continue through alternative mechanisms. Glioblastoma (GBM) is one such type of tumor that shows resistance to anti-VEGF therapy. Previously, we identified the hub genes differentially expressed in anti-VEGF resistance in GBM. Medhya Rasayana, an Ayurvedic formulation, is used for the management of neurological disorders. In the present study, we used computational docking methods to identify the phytochemicals present in the medicinal plants of Medhya Rasayana, which can target the proteins expressed by the hub genes associated with anti-VEGF resistance. Network pharmacological analysis was also performed to identify the highly effective phytochemicals for a possible adjuvant therapy. Results showed that multiple phytochemicals of Glycirrhiza glabra Linn, Evolvulus alsinoides, and Celastrus paniculatus target the anti-VGEF resistant proteins in GBM. This indicates the multi-targeting property of phytocompounds of Medhya Rasayana plants, which may be considered for adjuvant therapy along with anti-VEGF therapy.   Received: 10 July 2024 | Revised: 11 October 2024 | Accepted: 6 January 2025   Conflicts of Interest The authors declare that they have no conflicts of interest to this work.   Data Availability Statement The data that support this work are available upon reasonable request to the corresponding author.   Author Contribution Statement Kesavan R. Arya: Methodology, Formal analysis, Investigation, Writing - original draft, Writing - review & editing, Visualization, Funding acquisition. Sasikumar J. Soumya: Methodology, Formal analysis, Investigation, Writing - original draft, Writing - review & editing,Visualization, Funding acquisition. Anuroopa G. Nadh: Formal analysis, Investigation, Funding acquisition. Thankamani R. Aswathy: Formal analysis, Investigation. Vijayalakshmi B.: Investigation. Achuthsankar S. Nair: Resources, Project administration. Oommen V. Oommen: Validation, Resources, Writing - review & editing, Project administration. Perumana R. Sudhakaran: Conceptualization, Methodology, Validation, Investigation, Resources, Writing - review & editing, Project administration, Funding acquisition.
Title: <b>Multitarget-Directed Multiple Ligands in Anti-VEGF Resistant Glioblastoma Therapeutics: An in Silico Approach to Identify Potential Phytochemicals</b>
Description:
Angiogenesis is an important process in tumor progression.
Vascular endothelial growth factor (VEGF) is the key factor regulating angiogenesis, and hence, anti-VEGF therapy is considered a useful therapeutic approach in tumor conditions.
However, the drug resistance and lack of efficacy of existing drugs limit the potential of such a therapeutic approach in certain cases, and the tumor growth will continue through alternative mechanisms.
Glioblastoma (GBM) is one such type of tumor that shows resistance to anti-VEGF therapy.
Previously, we identified the hub genes differentially expressed in anti-VEGF resistance in GBM.
Medhya Rasayana, an Ayurvedic formulation, is used for the management of neurological disorders.
In the present study, we used computational docking methods to identify the phytochemicals present in the medicinal plants of Medhya Rasayana, which can target the proteins expressed by the hub genes associated with anti-VEGF resistance.
Network pharmacological analysis was also performed to identify the highly effective phytochemicals for a possible adjuvant therapy.
Results showed that multiple phytochemicals of Glycirrhiza glabra Linn, Evolvulus alsinoides, and Celastrus paniculatus target the anti-VGEF resistant proteins in GBM.
This indicates the multi-targeting property of phytocompounds of Medhya Rasayana plants, which may be considered for adjuvant therapy along with anti-VEGF therapy.
  Received: 10 July 2024 | Revised: 11 October 2024 | Accepted: 6 January 2025   Conflicts of Interest The authors declare that they have no conflicts of interest to this work.
  Data Availability Statement The data that support this work are available upon reasonable request to the corresponding author.
  Author Contribution Statement Kesavan R.
Arya: Methodology, Formal analysis, Investigation, Writing - original draft, Writing - review & editing, Visualization, Funding acquisition.
 Sasikumar J.
Soumya: Methodology, Formal analysis, Investigation, Writing - original draft, Writing - review & editing,Visualization, Funding acquisition.
Anuroopa G.
 Nadh: Formal analysis, Investigation, Funding acquisition.
Thankamani R.
Aswathy: Formal analysis, Investigation.
Vijayalakshmi B.
: Investigation.
Achuthsankar S.
Nair: Resources, Project administration.
Oommen V.
Oommen: Validation, Resources, Writing - review & editing, Project administration.
Perumana R.
Sudhakaran: Conceptualization, Methodology, Validation, Investigation, Resources, Writing - review & editing, Project administration, Funding acquisition.

Related Results

Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas
Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas
C. Christov, H. Adle‐Biassette, C. Le Guerinel, S. Natchev and R. K. Gherardi (1998) Neuropathology and Applied Neurobiology24, 29–35Immunohistochemical detection of vascular endot...
Targeting regulation of VEGF by BPTF in Non-Small Cell Lung Cancer and its potential clinical significance
Targeting regulation of VEGF by BPTF in Non-Small Cell Lung Cancer and its potential clinical significance
Abstract Purpose VEGF facilitates the formation of tumor angiogenesis, and bevacizumab targeting VEGF is used in anti-tumor therapy. It’s meaningful to clarify the upstrea...
Abstract 1842: Drug repurposing screen reveals glioblastoma cell line susceptibility to statins
Abstract 1842: Drug repurposing screen reveals glioblastoma cell line susceptibility to statins
Abstract Background: The standard therapy for glioblastoma patients is tumor resection followed by radiotherapy and temozolomide chemotherapy. Although glioblastoma ...
Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A
Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A
AbstractDuring bone formation and fracture healing there is a cross-talk between endothelial cells and osteoblasts. We previously showed that vascular endothelial growth factor A (...
Abstract 1803: Combining anti-Ang-2/VEGF-A therapy with radio- and chemotherapy in glioma
Abstract 1803: Combining anti-Ang-2/VEGF-A therapy with radio- and chemotherapy in glioma
Abstract Angiogenesis is a biological hallmark of malignant gliomas, but antiangiogenic strategies especially targeting the VEGF axis did not show striking antitumor...
Impact of hypoxia induced VEGF and its signaling during caudal fin regeneration in Zebrafish
Impact of hypoxia induced VEGF and its signaling during caudal fin regeneration in Zebrafish
ABSTRACT:Hypoxia is known to play important role during various cellular process, including regeneration. Regeneration is a complex process involving wound healing and tissue repai...

Back to Top